Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20042226HPVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS20048727HPVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS20049028HPVENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS44008648HTLV-1ENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS44034357HTLV-1ENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS44046431HTLV-1ENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS44040446HTLV-1ENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TVIS44040618HTLV-1ENSG00000107643.17protein_codingMAPK8NoNo5599A1L4K2
P45983
TCGA Plot Options
Drug Information
GeneMAPK8
DrugBank IDDB00675
Drug NameTamoxifen
Target IDBE0003790
UniProt IDP45983
Regulation Typemodulator
PubMed IDs27083550
CitationsRadin DP, Patel P: Delineating the molecular mechanisms of tamoxifen's oncolytic actions in estrogen receptor-negative cancers. Eur J Pharmacol. 2016 Jun 15;781:173-80. doi: 10.1016/j.ejphar.2016.04.017. Epub 2016 Apr 12.
GroupsApproved
Direct ClassificationStilbenes
SMILESCCC(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
PathwaysTamoxifen Metabolism Pathway; Tamoxifen Action Pathway
PharmGKBPA451581
ChEMBLCHEMBL83